First Nationwide Use of Bracco's VUEWAY (gadopiclenol) Solut

Requiring half the gadolinium dosage compared to other macrocyclic gadolinium-based contrast agents (GBCAs) in approved indications in the U.S., gadopiclenol also has the highest relaxivity compared to approved GBCAs1-7

Related Keywords

Chicago , Illinois , United States , Max Wintermark , Emanuel Kanal , Fulvio Renoldi Bracco , Bayer Healthcare Pharmaceuticals Inc , Wellstar Health System , Liebel Flarsheim Company , Bracco Diagnostics Inc , Ge Healthcare , Bracco Imaging , Pharmacokinetic Profiles , New Macrocyclic Gadolinium Chelate , Invest Radiol , Full Prescribing , Bayer Healthcare Pharmaceuticals , Full Prescribing Information , Patient Medication , Monroe Twp , Injection Full Prescribing , Current Challenges , Central Nervous , Clinical Study Report , Show Serious , Concerns Remain , Contrast Safety ,